By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



One MedImmune Way

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-398-0000 Fax: 301-398-9000


MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.

With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.

Key Statistics

Ownership: Public

Web Site: MedImmune
Employees: 3,000
Symbol: AZN


Company News
TapImmune (TPIV) Announces Phase 2 Ovarian Cancer Trial Study With AstraZeneca PLC (AZN)/MedImmune (AZN) And Sloan Kettering Cancer Institute 4/21/2016 7:47:16 AM
MedImmune (AZN) Release: Second Annual Regional Biotech Forum Brings Industry, Academia, Government Together To Raise Region’s Prominence As Top Biotech Hub 4/18/2016 11:20:42 AM
Humabs Biomed Reports Regulatory Milestone In MedImmune (AZN) Partnership 3/23/2016 9:16:23 AM
Health Canada, European Medicines Agency, Amgen (AMGN), Pfizer (PFE), AGES, MedImmune (AZN) And More To Discuss The Challenges In Biosimilar Drug Development At The Upcoming IQPC Summit 3/17/2016 9:55:45 AM
Johns Hopkins University And MedImmune (AZN) Announce Joint Program To Train Ph.D. Students For Careers In Biopharma 3/2/2016 3:51:13 PM
Immunocore Starts Clinical Trial With IMCgp100 In Combination With MedImmune (AZN) Immunotherapies Durvalumab And Tremelimumab 1/20/2016 6:02:01 AM
Cepheid (CPHD) Announces Diagnostic Collaboration With MedImmune (AZN) And COMBACTE To Facilitate Clinical Trials Of New Monoclonal Antibodies To Prevent Serious Infectious Diseases 1/14/2016 7:01:06 AM
Rani Therapeutics Announces Collaboration With MedImmune (AZN) In The Metabolic Disease Field 1/6/2016 9:28:32 AM
Unilife  (UNIS) Signs Commercial Supply Agreement Wth MedImmune (AZN) 11/4/2015 7:34:24 AM
Igenica, Inc. Enters Into A Strategic Oncology Research Agreement With MedImmune (AZN) 10/28/2015 6:39:22 AM